Suvretta Capital Management, LLC Erasca, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.39 Billion
- Q2 2024
A detailed history of Suvretta Capital Management, LLC transactions in Erasca, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 13,768,039 shares of ERAS stock, worth $40.8 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
13,768,039Holding current value
$40.8 Million% of portfolio
1.36%Shares
1 transactions
Others Institutions Holding ERAS
# of Institutions
133Shares Held
205MCall Options Held
3.1KPut Options Held
142K-
Frazier Life Sciences Management, L.P. Menlo Park, CA16.2MShares$48 Million2.26% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$48 Million4.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL11.1MShares$32.7 Million15.29% of portfolio
-
Black Rock Inc. New York, NY10.6MShares$31.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.4MShares$30.6 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $362M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...